implement process innovation and drive your product from manufacture to market. That’s why the 2019 Cell and Gene Therapy Manufacturing Forum is our biggest yet. With content from over 18 ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

High manufacturing costs limit access to cell and gene therapies and make it harder to bring new products to market, according to VIVEbiotech CEO, Jon Alberdi, who says cheaper production ...

Kaczmarek is a recognized expert in gene therapy manufacturing ... a contract development and manufacturing organization (CDMO) specializing in viral vector process development, GMP manufacturing ...

Over 300 million people worldwide live with a genetic disease, and there are over 7,000 rare diseases with no cure. Sheffield’s Gene Therapy Innovation and Manufacturing Centre is set to accelerate ...

Gene therapy is referred to as a medical ... are customized for personalized therapies and decentralized manufacturing, real-time process control with the help of advanced inline and online ...